Francois Rochon - Giverny Capital

Holding/activity history for  Edwards Lifesciences Corp. (EW)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q4 440,906 1.58 Add 0.07% 0.00 $76.25
2023   Q3 440,602 1.66 Add 0.16% 0.00 $69.28
2023   Q2 439,896 2.18 Add 6.01% 0.12 $94.33
2023   Q1 414,975 2.07 Reduce 2.63% 0.06 $82.73
2022   Q4 426,173 1.97 Reduce 0.94% 0.02 $74.61
2022   Q3 430,196 2.41 Add 3.19% 0.07 $82.63
2022   Q2 416,882 2.61 Add 2.91% 0.07 $95.09
2022   Q1 405,091 2.69 Reduce 0.17% 0.00 $117.72
2021   Q4 405,762 2.80 Add 0.90% 0.02 $129.55
2021   Q3 402,150 2.71 Reduce 0.83% 0.02 $113.21
2021   Q2 405,529 2.55 Add 3.94% 0.10 $103.57
2021   Q1 390,140 2.18 Add 0.60% 0.01 $83.64
2020   Q4 387,814 2.71 Add 3.85% 0.10 $91.23
2020   Q3 373,422 2.73 Add 0.21% 0.01 $79.82
2020   Q2 372,627 2.56 Add 214.65% 1.75 $69.11
2020   Q1 118,426 2.84 Reduce 7.85% 0.24 $188.62
2019   Q4 128,515 2.71 Add 1.01% 0.03 $233.29
2019   Q3 127,233 2.79 Add 0.19% 0.01 $219.91
2019   Q2 126,990 2.37 Add 2.47% 0.06 $184.74
2019   Q1 123,923 2.72 Add 1.43% 0.04 $191.33
2018   Q4 122,178 2.47 Reduce 32.38% 1.18 $153.17
2018   Q3 180,690 3.56 Add 4.74% 0.16 $174.10
2018   Q2 172,508 3.27 Add 0.78% 0.03 $145.57
2018   Q1 171,166 3.20 Add 5.94% 0.18 $139.52
2017   Q4 161,571 2.50 $112.71